Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Boston Scientific | 46 | 0 | 13 | 0 | €68.50 | €73.05 | 6.638% |
Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €462.95 | €543.72 | 17.447% |
Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
Humana Inc. | 23 | 0 | 6 | 0 | €286.00 | €439.88 | 53.803% |
Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | €536.00 | €566.65 | 5.718% |
Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
Staar Surgical Co. | 11 | 1 | 4 | 0 | €43.86 | €49.02 | 11.760% |
Centene Corp. | 13 | 0 | 4 | 0 | €69.16 | €82.26 | 18.935% |
Merck & Co. Inc. | 28 | 1 | 4 | 0 | €122.60 | €124.93 | 1.900% |
Biogen Inc. | 44 | 1 | 4 | 0 | €195.30 | €294.45 | 50.767% |
Align Technology | 16 | 2 | 4 | 0 | €288.90 | €345.95 | 19.747% |
Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €350.70 | €370.00 | 5.503% |
Stryker Corp. | 17 | 0 | 4 | 0 | €313.60 | €331.52 | 5.716% |
Abbott Laboratories | 16 | 0 | 4 | 0 | €100.48 | €116.81 | 16.250% |
Resmed Inc. | 19 | 0 | 4 | 0 | €203.80 | €207.72 | 1.921% |
Eli Lilly Corp. | 47 | 0 | 4 | 0 | €685.20 | €753.63 | 9.987% |
Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.16 | €11.05 | 249.633% |
Dexcom Inc. | 18 | 0 | 3 | 0 | €116.18 | €136.82 | 17.767% |
Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.29 | €4.57 | 99.381% |
MacroGenics Inc. | 11 | 0 | 3 | 0 | €13.58 | €20.00 | 47.275% |
CONMED Corp. | 11 | 1 | 3 | 0 | €60.00 | €109.59 | 82.642% |
Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.58 | €27.00 | 114.527% |
Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |